June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
The effect of blocking substance P in reducing ocular redness
Author Affiliations & Notes
  • Shudan Wang
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Harbin Medical University, Harbin, Heilongjiang, China
  • Lingjia Liu
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Tomas Blanco
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • shuyan zhu
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Kunpeng Pang
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Hongyan Ge
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Yihe Chen
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Reza Dana
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Shudan Wang, None; Lingjia Liu, None; Tomas Blanco, None; shuyan zhu, None; Kunpeng Pang, None; Hongyan Ge, None; Yihe Chen, None; Reza Dana, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 399. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shudan Wang, Lingjia Liu, Tomas Blanco, shuyan zhu, Kunpeng Pang, Hongyan Ge, Yihe Chen, Reza Dana; The effect of blocking substance P in reducing ocular redness. Invest. Ophthalmol. Vis. Sci. 2021;62(8):399.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Various clinical conditions may cause dilation of the conjunctival vessels, leading to ocular redness (OR), among which allergic conjunctivitis is the most common cause, followed by dry eye disease and infectious conjunctivitis. Herein, using animal models of both allergic and non-allergic OR, we evaluated the therapeutic efficacy of topical blockade of substance P (SP) in treating the red eye.

Methods : Allergic OR was induced in Guinea pigs with topical 1.5 mg/mL histamine, and non-allergic OR was induced in rabbits with topical 5% dapiprazole. Once topical histamine or dapiprazole was applied, animals immediately received topical treatment of L-703,606, a SP receptor antagonist, or vehicle. Animal eyes were thereafter examined by a slit lamp, and images were taken every 30 seconds in the first 2 minutes, and then at 6, 10, 20, 30, 40, 50, and 60 minutes post treatment. The severity of redness was analyzed using ocular redness index (ORI) which is a continuous numerical score from 0 to 100.

Results : In the vehicle control group, the ORI reached peak at 10 minutes in allergic OR and the maximal increase from baseline was 17.04. In the non-allergic OR model, maximal increase in ORI score is 13.07 at peak time of 20 minutes post-induction. Topical treatment of L-703,606 significantly reduced ORI at each time point evaluated in both allergic and non-allergic OR models. At peak time, L-703,606 treated group showed ORI reduction of 8.21 in allergic model and 5.76 in non-allergic model, respectively.

Conclusions : Topical blockade of SP is effective for treating allergic and non-allergic red eye.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×